RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS | NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding Public Warrants (as defined in Note 5) and Private Placement Warrants (collectively, with the Public Warrants, the “Warrants”) issued in connection with its Initial Public Offering and concurrent private placement as components of equity instead of as derivative liabilities. The warrant agreement governing the Warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender offer or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of stock, all holders of the Warrants would be entitled to receive cash for their Warrants (the “tender offer provision”). On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the Securities and Exchange Commission together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). Specifically, the SEC Staff Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement. In consideration of the SEC Staff Statement, the Company’s management further evaluated the Warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on its evaluation, management concluded that the Company’s Private Placement Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the tender offer provision fails the “classified in stockholders’ equity” criteria as contemplated by ASC Section 815-40-25. In accordance with ASC 825-10, Financial Instruments, as a result of the classification of the warrants as derivative liabilities, the Company expensed a portion of the offering costs originally recorded as a reduction in equity. The portion of offering costs that was expensed was determined based on the relative fair value of the Public Warrants and shares of Class A common stock included in the Units. As a result of the above, the Company should have classified the Warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the Warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. As Previously Reported Adjustments As Restated Balance sheet as of October 6, 2020 (audited) Warrant Liability, at fair value $ — $ 27,061,145 $ 27,061,145 Total liabilities 14,551,035 27,061,145 41,612,180 Class A Common Stock Subject to Possible Redemption 382,455,490 (27,061,140 ) 355,394,350 Class A Common Stock 175 271 446 Additional Paid-in Capital 4,999,681 1,028,582 6,028,263 Accumulated Deficit (1,000 ) (1,028,858 ) (1,029,858 ) Stockholders’ Equity 5,000,006 (5 ) 5,000,001 Balance sheet as of December 31, 2020 (audited) Warrant Liability, at fair vlaue $ — $ 45,225,000 $ 45,225,000 Total liabilities 15,875,583 45,225,000 61,100,583 Class A Common Stock Subject to Possible Redemption 430,570,380 (45,225,000 ) 385,345,380 Class A Common Stock 194 453 647 Additional Paid-in Capital 5,134,797 16,159,456 21,294,253 Accumulated Deficit (136,110 ) (16,159,909 ) (16,296,019 ) Statement of Operations for the Period from July 30 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ (15,007,134 ) $ (15,007,134 ) Transaction costs allocated to warrant liabilities — (1,152,775 ) (1,152,775 ) Net loss (136,110 ) (16,159,909 ) (16,296,019 ) Weighted average shares outstanding, Class A Common stock subject to possible redemption 45,000,000 (470,588 ) 44,529,412 Basic and diluted net income per share, Class A Common stock subject to possible redemption 0.00 — 0.00 Weighted average shares outstanding, Class B Common stock 11,250,000 (567,376 ) 10,682,624 Basic and diluted net loss per share, Class B Common stock (0.01 ) (1.52 ) (1.53 ) Cash Flow Statement for the Period from July 30, 2020 (inception) to December 31, 2020 (audited) Net loss $ (136,110 ) $ (16,159,909 ) $ (16,296,019 ) Change in fair value of warrant liability — 15,007,134 15,007,134 Transaction costs allocated to warrant liabilities — 1,152,775 1,152,775 Initial classification of Class A common stock subject to possible redemption 430,705,490 (30,217,870 ) 400,487,620 Change in value of Class A common stock subject to possible redemption (135,110 ) (15,007,130 ) (15,142,240 ) |